IL23A and inflammatory bowel disease: In one study, the depletion of IL-23 via the genetic ablation of IL-23p19 or using antibodies led to the attenuation of T-cell-dependent colitis in models of IBD [119] and restained spontaneous colitis in mice, which confirmed the hypothesis that IL-23 plays a role in IBD [120].